Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.69+0.01 (+2.10%)
Close on Nov 18, 2026Market cap $8.09MP/E –Yield –
Radiopharm Theranostics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2026 it was -$56.78M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$56.78M | – |
| FY2025 | Jun 30, 2025 | -$38.17M | – |
| FY2024 | Jun 30, 2024 | -$47.21M | – |
| FY2023 | Jun 30, 2023 | -$34.49M | – |
See a number that looks wrong?